Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00922831

Progression of Cognitive and Physical Symptoms in Multiple Sclerosis

Progression of Cognitive, Affective, and Physical Symptoms in Multiple Sclerosis.

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to look at multiple sclerosis patients process of awareness, learning, and judging status over a 3 year time period.

Detailed description

Patients with multiple sclerosis (MS) frequently experience cognitive and emotional difficulties. Theses neuropsychiatric symptoms are known to be associated with reduced quality of life. However, little is known about the evolution of MS patients' neuropsychiatric difficulties and how these neuropsychiatric changes may be related to other MS symptoms. The purpose of the present study is to examine MS patients' cognitive and emotional status over time as part of standard neuropsychological evaluations in a private practice setting. MS patients presenting for neuropsychological evaluation at the MidAmerica Neuroscience Institute will be provided with the option of participating in thorough evaluation of their cognitive and affective MS symptoms. They will then be followed clinically and receive re-evaluation over a period of 3 years on a yearly basis. It is hoped that this study will help us obtain a better understanding of the factors associated with worsening cognition in MS. A greater understanding of the factors associated with cognitive and affective decline in MS help could lead to the early identification and treatment of at-risk patients.

Conditions

Timeline

Start date
2008-08-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2009-06-17
Last updated
2018-04-12

Source: ClinicalTrials.gov record NCT00922831. Inclusion in this directory is not an endorsement.